A New Once-Daily Pill to Treat HIV Just Got the FDA’s Green Light
Bixlenvo offers a simplified option for patients whose HIV is under control but who can’t use current single-pill treatments.
August 31 2026 2:31 PM
By continuing to use our site, you agree to our Privacy Policy and Terms of Use.
Bixlenvo offers a simplified option for patients whose HIV is under control but who can’t use current single-pill treatments.
Paxlovid ensures that adults have continued access to treatment, but is not authorized as a COVID-19 preventative.
The drug has become a pop culture darling after its weight loss potential was promoted on social media.